Table 2 Prevalence of acute and chronic symptoms among COVID-19 patients with and without long-COVID.
Label | Variable | Long-COVID | Total (N: 11,801) | Difference (P value) | |
|---|---|---|---|---|---|
No (N: 9466) | Yes (N: 2335) | ||||
Respiratory parameters | |||||
Anosmia | No | 7290 (79.9%) | 1832 (20.0%) | 9122 (77.3%) | 0.135 |
Yes | 2176 (81.2%) | 503 (18.7%) | 2679 (22.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Asthma | No | 8732 (80.3%) | 2137 (19.6%) | 10,869 (92.1%) | 0.244 |
Yes | 734 (78.7%) | 198 (21.2%) | 932 (7.9%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Chest pain | No | 8047 (82.3%) | 1725 (17.6%) | 9772 (82.8%) | ≤ 0.001 |
Yes | 1419 (69.9%) | 610 (30.0%) | 2029 (17.1%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Cough | No | 4062 (79.8%) | 1023 (20.1%) | 5085 (43.0%) | 0.431 |
Yes | 5404 (80.4%) | 1312 (19.5%) | 6716 (56.9%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Runny nose | No | 6286 (79.8%) | 1587 (20.1%) | 7873 (66.7%) | 0.152 |
Yes | 3180 (80.9%) | 748 (19.0%) | 3928 (33.2%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
SOB | No | 7053 (83.0%) | 1437 (16.9%) | 8490 (71.9%) | ≤ 0.001 |
Yes | 2413 (72.8%) | 898 (27.1%) | 3311 (28.0%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Sore throat | No | 5750 (81.0%) | 1349 (19.0%) | 7099 (60.1%) | 0.009 |
Yes | 3716 (79.0%) | 986 (20.9%) | 4702 (39.8%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Constitutional and neurologic | |||||
Confusion | No | 8659 (80.3%) | 2112 (19.6%) | 10,771 (91.2%) | 0.116 |
Yes | 807 (78.3%) | 223 (21.6%) | 1030 (8.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Conjunctivitis | No | 9003 (80.0%) | 2238 (19.9%) | 11,241 (95.2%) | 0.134 |
Yes | 463 (82.6%) | 97 (17.3%) | 560 (4.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Dysgeusia | No | 6987 (82.4%) | 1486 (17.5%) | 8473 (71.8%) | ≤ 0.001 |
Yes | 2479 (74.4%) | 849 (25.5%) | 3328 (28.2%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Fatigue | No | 4404 (86.0%) | 713 (13.9%) | 5117 (43.3%) | ≤ 0.001 |
Yes | 5062 (75.7%) | 1622 (24.2%) | 6684 (56.6%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Fever | No | 4138 (80.9%) | 977 (19.1%) | 5115 (43.3%) | 0.102 |
Yes | 5328 (79.6%) | 1358 (20.3%) | 6686 (56.6%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
History of stroke | No | 9370 (80.2%) | 2312 (19.7%) | 11,682 (98.9%) | 0.900 |
Yes | 96 (80.6%) | 23 (19.3%) | 119 (1.0%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Migraine | No | 8481 (81.2%) | 1954 (18.7%) | 10,435 (88.4%) | ≤ 0.001 |
Yes | 985 (72.1%) | 381 (27.8%) | 1366 (11.5%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Muscle joint symptoms | No | 4499 (86.0%) | 732 (13.9%) | 5231 (44.3%) | ≤ 0.001 |
Yes | 4967 (75.6%) | 1603 (24.4%) | 6570 (55.6%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Rash | No | 8956 (80.1%) | 2224 (19.8%) | 11,180 (94.7%) | 0.219 |
Yes | 510 (82.1%) | 111 (17.8%) | 621 (5.2%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
GI symptoms | No | 5758 (82.6%) | 1206 (17.3%) | 6964 (59.0%) | ≤ 0.001 |
Yes | 3708 (76.6%) | 1129 (23.3%) | 4837 (40.9%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Insomnia | No | 8772 (80.8%) | 2081 (19.1%) | 10,853 (91.9%) | ≤ 0.001 |
Yes | 694 (73.2%) | 254 (26.7%) | 948 (8.0%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Comorbidities | |||||
Anemia | No | 8751 (80.8%) | 2072 (19.1%) | 10,823 (91.7%) | ≤ 0.001 |
Yes | 715 (73.1%) | 263 (26.8%) | 978 (8.2%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Autoimmune disease | No | 9079 (80.4%) | 2202 (19.5%) | 11,281 (95.5%) | 0.001 |
Yes | 387 (74.4%) | 133 (25.5%) | 520 (4.4%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Cancer | No | 9402 (80.2%) | 2314 (19.7%) | 11,716 (99.2%) | 0.253 |
Yes | 64 (75.2%) | 21 (24.7%) | 85 (0.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
COPD | No | 9364 (80.2%) | 2303 (19.7%) | 11,667 (98.8%) | 0.232 |
Yes | 102 (76.1%) | 32 (23.8%) | 134 (1.1%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Diabetes type 1 | No | 9293 (80.1%) | 2304 (19.8%) | 11,597 (98.2%) | 0.097 |
Yes | 173 (84.8%) | 31 (15.2%) | 204 (1.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Diabetes type 2 | No | 9106 (80.2%) | 2243 (19.7%) | 11,349 (96.1%) | 0.757 |
Yes | 360 (79.6%) | 92 (20.3%) | 452 (3.8%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Immunosuppression | No | 9239 (80.3%) | 2263 (19.6%) | 11,502 (97.4%) | 0.059 |
Yes | 227 (75.9%) | 72 (24.0%) | 299 (2.5%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
GI disease | No | 9051 (80.8%) | 2146 (19.1%) | 11,197 (94.8%) | ≤ 0.001 |
Yes | 415 (68.7%) | 189 (31.2%) | 604 (5.1%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Heart disease | No | 9173 (80.1%) | 2266 (19.8%) | 11,439 (96.9%) | 0.725 |
Yes | 293 (80.9%) | 69 (19.0%) | 362 (3.0%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Hypertension | No | 8652 (80.3%) | 2121 (19.6%) | 10,773 (91.2%) | 0.385 |
Yes | 814 (79.1%) | 214 (20.8%) | 1028 (8.7%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Renal disease | No | 9362 (80.2%) | 2304 (19.7%) | 11,666 (98.8%) | 0.352 |
Yes | 104 (77.0%) | 31 (22.9%) | 135 (1.1%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
Seizure | No | 9357 (80.2%) | 2310 (19.8%) | 11,667 (98.8%) | 0.741 |
Yes | 109 (81.3%) | 25 (18.6%) | 134 (1.1%) | ||
Total | 9466 (80.2%) | 2335 (19.7%) | 11,801 (100.0%) | ||
